Skip to content

CME Group CME Free cash flow

Free cash flow at other companies

BGC Group, Inc. logo
BGC Group, Inc.BGC
$15.37M+448%
MarketAxess logo
MarketAxessMKTX
-$75.59M-373%
Cboe Global Markets logo
Cboe Global MarketsCBOE
$1.94B+116%
Intercontinental Exchange logo
Intercontinental ExchangeICE
$1.26B+43.2%
Nasdaq, Inc. logo
Nasdaq, Inc.NDAQ
$629M+2.4%
Tradeweb Markets Inc. logo
Tradeweb Markets Inc.TW

Other financials

Income statement

See full
Revenue$1.9B+14.5%
Operating income$1.3B+18.2%
Net income$1.2B+23.7%
EPS (diluted)$3.18+21.4%

Balance sheet

See full
Cash & equivalents$2.4B+70.2%
Total debt$3.7B-1.4%
Total equity$26.6B-1.5%
Total assets$201.99B+28.0%

Cash flow

See full
Operating cash flow$1.3B+12.8%
CapEx$21.8M+53.5%

Valuation

See full
Market cap$81.3B-17.7%
Enterprise value$82.65B-18.3%
P/E18.9×-8.3×
P/S12×-3.7×

Profitability

See full
Operating margin65.6%+0.6pp
Net margin63.6%+5.9pp
FCF margin64.1%+3.2pp

Returns & leverage

See full
Return on equity16%+2.6pp
Debt / equity0.1×0.0×
Current ratio0.0×

Where this comes from

Calculated from CME Group’s reported figures.

The official record: CME Group’s 10-Q, filed April 24, 2026, on SEC EDGAR. View the filing →

Ask your AI about CME Group's free cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CME Group's free cash flow?
CME Group (CME) reported free cash flow of $1.24B in Q1 2026.
How has CME Group's free cash flow changed year-over-year?
CME Group's free cash flow increased by 12.3% year-over-year, from $1.1B to $1.24B.
What is the long-term trend for CME Group's free cash flow?
Over 4 years (2021 to 2025), CME Group's free cash flow has grown at a 16.5% compound annual growth rate (CAGR), from $2.28B to $4.19B.
What does free cash flow mean?
Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.